Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin - PubMed (original) (raw)
. 2002 May 21;41(20):6245-52.
doi: 10.1021/bi025599p.
Affiliations
- PMID: 12009885
- DOI: 10.1021/bi025599p
Relationship between protein structure and methionine oxidation in recombinant human alpha 1-antitrypsin
Steven W Griffiths et al. Biochemistry. 2002.
Abstract
alpha 1-Antitrypsin is a metastable and conformationally flexible protein that belongs to the serpin family of protease inhibitors. Although it is known that methionine oxidation in the protein's active site results in a loss of biological activity, there is little specific knowledge regarding the reactivity of each of the protein's methionine residues. In this study, we have used peptide mapping to study the oxidation kinetics of each of alpha 1-antitrypsin's methionines in alpha 1-AT((C232S)) as well as M351L and M358V mutants. These kinetic studies establish that Met1, Met226, Met242, Met351, and Met358 are reactive with hydrogen peroxide at neutral pH and that each reactive methionine is oxidized in a bimolecular, rather than coupled, mechanism. Analysis of Met226, Met351, and Met358 oxidation provides insights regarding the structure of alpha 1-antitrypsin's active site that allow us to relate conformation to experimentally observed reactivity. The relationship between solution pH and methionine oxidation was also examined to evaluate methionine reactivity under conditions that perturb the native structure. Methionine oxidation data show that at pH 5, global conformational changes occur that alter the oxidation susceptibility of each of alpha 1-antitrypsin's 10 methionine residues. Between pH 6 and 9, however, more localized conformational changes occur that affect primarily the reactivity of Met242. In sum, this work provides a detailed analysis of methionine oxidation in alpha 1-antitrypsin and offers new insights into the protein's solution structure.
Similar articles
- Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity.
Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL. Taggart C, et al. J Biol Chem. 2000 Sep 1;275(35):27258-65. doi: 10.1074/jbc.M004850200. J Biol Chem. 2000. PMID: 10867014 - The reactivity and oxidation pathway of cysteine 232 in recombinant human alpha 1-antitrypsin.
Griffiths SW, King J, Cooney CL. Griffiths SW, et al. J Biol Chem. 2002 Jul 12;277(28):25486-92. doi: 10.1074/jbc.M203089200. Epub 2002 May 3. J Biol Chem. 2002. PMID: 11991955 - Probing the local conformational change of alpha1-antitrypsin.
Baek JH, Im H, Kang UB, Seong KM, Lee C, Kim J, Yu MH. Baek JH, et al. Protein Sci. 2007 Sep;16(9):1842-50. doi: 10.1110/ps.072911607. Epub 2007 Jul 27. Protein Sci. 2007. PMID: 17660256 Free PMC article. - Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy.
Lomas DA, Mahadeva R. Lomas DA, et al. J Clin Invest. 2002 Dec;110(11):1585-90. doi: 10.1172/JCI16782. J Clin Invest. 2002. PMID: 12464660 Free PMC article. Review. No abstract available. - Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies.
Crowther DC, Belorgey D, Miranda E, Kinghorn KJ, Sharp LK, Lomas DA. Crowther DC, et al. Eur J Hum Genet. 2004 Mar;12(3):167-72. doi: 10.1038/sj.ejhg.5201127. Eur J Hum Genet. 2004. PMID: 14694355 Review.
Cited by
- Stability of Protein Pharmaceuticals: Recent Advances.
Manning MC, Holcomb RE, Payne RW, Stillahn JM, Connolly BD, Katayama DS, Liu H, Matsuura JE, Murphy BM, Henry CS, Crommelin DJA. Manning MC, et al. Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27. Pharm Res. 2024. PMID: 38937372 Review. - Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?
D'Amato M, Campagnoli M, Iadarola P, Bignami PM, Fumagalli M, Chiarelli LR, Stelitano G, Meloni F, Linciano P, Collina S, Pietrocola G, Vertui V, Aliberti A, Fossali T, Viglio S. D'Amato M, et al. Int J Mol Sci. 2023 Aug 31;24(17):13533. doi: 10.3390/ijms241713533. Int J Mol Sci. 2023. PMID: 37686340 Free PMC article. - Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma.
Chitranshi N, Rajput R, Godinez A, Pushpitha K, Mirzaei M, Basavarajappa D, Gupta V, Sharma S, You Y, Galliciotti G, Salekdeh GH, Baker MS, Graham SL, Gupta VK. Chitranshi N, et al. Mol Ther. 2023 Jul 5;31(7):2056-2076. doi: 10.1016/j.ymthe.2023.03.008. Epub 2023 Mar 11. Mol Ther. 2023. PMID: 36905120 Free PMC article. - Re-mining serum proteomics data reveals extensive post-translational modifications upon Zika and dengue infection.
Allgoewer K, Wu S, Choi H, Vogel C. Allgoewer K, et al. Mol Omics. 2023 May 9;19(4):308-320. doi: 10.1039/d2mo00258b. Mol Omics. 2023. PMID: 36810580 Free PMC article. - A novel method for in silico assessment of Methionine oxidation risk in monoclonal antibodies: Improvement over the 2-shell model.
Tavella D, Ouellette DR, Garofalo R, Zhu K, Xu J, Oloo EO, Negron C, Ihnat PM. Tavella D, et al. PLoS One. 2022 Dec 29;17(12):e0279689. doi: 10.1371/journal.pone.0279689. eCollection 2022. PLoS One. 2022. PMID: 36580468 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources